FCGR2B and scleroderma: The levels of FcγRIIB expression on DN memory B cells may correlate with disease severity, since the European Scleroderma Group-Activity Index (EScG-AI) was significantly increased in patients with higher levels of FcγRIIB compared to those with normal FcγRIIB levels on the surface of DN memory B cells.